In 2026, consumer wearables do more. They can flag patterns that may point to real health problems, not just a rough wellness trend.

At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people ...

Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...

Opportunities include integrating digital health for remote care, leveraging demographic trends, and overcoming CGM unit costs to expand access across regionsDublin, March 16, 2026 (GLOBE NEWSWIRE) -- ...

Researchers have found in a new study that continuous glucose monitoring (CGM) in the ICU appears to provide reliable glucose ...

New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics and hypoglycemic outcomes Eversense 365 delivered ...

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology at ATTD 2026.

At 45, Lance Bass says he is "the healthiest I've ever been." The singer, actor and entertainer best known for his time in NSYNC, came to South by Southwest on Tuesday to talk about chronic illness ...

Collaboration expands access to trusted therapies with discounted cash prices for leading brands including Lipitor®, ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of ...